European Biotechnology Magazine Winter 2023
Berlin, 6 December 2023 – Cellular Agriculture: Boom or Exodus? Is Europe once again becoming dependent on the USA and Asia – this time in the potential billion-dollar market for cell-based meat, fish, and dairy products? More than 90% of EU biotech companies with relevant product portfolios are opting for approval in Singapore or the USA, as the EU Food Authority reacts slowly and investment in industrial production facilities is hesitant. Dubai is also trying to attract EU innovators with large capital investments.
In this issue:
- Cancer: Progress in Antibody-Drug Conjugates (ADCs) for Solid Tumours
- Special: Bioparks and Production – Square Metres: the New Gold
- Action Plan Needed – Interview with Marco Rupp, Biobased Industries Consortium, on the success of the biobased circular economy
- The EU Exodus of Biotechnology
Europe is the birthplace of the cell-based meat sector. Companies that have developed microbiological, fungal, and cell-based alternatives to conventional meat, fish, or dairy products – or to plant-based protein alternatives, which are often expensive and unpalatable – are facing significant hurdles when it comes to approval and production on the continent. Will these companies soon leave Europe? - Euro BioFairs Compass – Events in the first half of 2024
- News from the Swiss Biotech Association, BIOTECH Austria, Young European Biotech Network
Read the Spring/2023 issue here.